KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Chemistry / 2007 / Cilt: 31 - Sayı: 2

Synthesis of 2-Acylamino, 2-Aroylamino and Ethoxycarbonyl Imino-1,3,4-thiadiazoles as Antitumor Agents

Kemal SANCAK
Yasemin ÜNVER
Mustafa ER
Sayfa
125–134
Yayın Tarihi
2007-02-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The in vitro antitumor activities of some selected compounds were screened and compounds 2a, 2b, 2c, 3a, 3b, 3c, 5a, 5b and 5c were found to be active.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:2-Amino-1,3,4-thiadiazoles compounds (2a-e) were obtained from the reaction of thiosemi carbazide with 2-cyanomethoxyphenoxyacetonitriles (1).
📊
Temel Bulgular & Veri:Mono acylamino, mono aroylamino and diethoxycarbonyl imino-1,3,4-thiadiazole compounds (3a-e, 4a-e, 5a-c) were synthesized via the reaction of 2-amino-1,3,4-thiadiazole compounds (2a-e) with acetyl chloride or acetic anhydride, benzoyl chloride or benzoic anhydride and ethyl chloroformate, respectively.
💡
Sonuç & Katkı:The in vitro antitumor activities of some selected compounds were screened and compounds 2a, 2b, 2c, 3a, 3b, 3c, 5a, 5b and 5c were found to be active.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:4-Thiadiazole · acetyl chloride · benzoyl chloride

Özet

2-Amino-1,3,4-thiadiazoles compounds (2a-e) were obtained from the reaction of thiosemi carbazide with 2-cyanomethoxyphenoxyacetonitriles (1). Mono acylamino, mono aroylamino and diethoxycarbonyl imino-1,3,4-thiadiazole compounds (3a-e, 4a-e, 5a-c) were synthesized via the reaction of 2-amino-1,3,4-thiadiazole compounds (2a-e) with acetyl chloride or acetic anhydride, benzoyl chloride or benzoic anhydride and ethyl chloroformate, respectively. The in vitro antitumor activities of some selected compounds were screened and compounds 2a, 2b, 2c, 3a, 3b, 3c, 5a, 5b and 5c were found to be active.

Abstract

2-Amino-1,3,4-thiadiazoles compounds (2a-e) were obtained from the reaction of thiosemi carbazide with 2-cyanomethoxyphenoxyacetonitriles (1). Mono acylamino, mono aroylamino and diethoxycarbonyl imino-1,3,4-thiadiazole compounds (3a-e, 4a-e, 5a-c) were synthesized via the reaction of 2-amino-1,3,4-thiadiazole compounds (2a-e) with acetyl chloride or acetic anhydride, benzoyl chloride or benzoic anhydride and ethyl chloroformate, respectively. The in vitro antitumor activities of some selected compounds were screened and compounds 2a, 2b, 2c, 3a, 3b, 3c, 5a, 5b and 5c were found to be active.

🔖

Bu Makaleye Atıf Yap

SANCAK, K., ÜNVER, Y., ER, M. (2007). Synthesis of 2-Acylamino, 2-Aroylamino and Ethoxycarbonyl Imino-1,3,4-thiadiazoles as Antitumor Agents. Turkish Journal of Chemistry, Cilt: 31 - Sayı: 2, 125–134. https://ajindex.com/articles/185059

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (20)

  1. P.C. Unangst, G.P. Shrum, D.T. Dyer and D.J. Schrier, J. Med. Chem. 35, 3691-98 (1992).
  2. M.D. Mullican, M.W. Wilson, D.T. Connor, C.R. Kostlan and D.J. Schrier, J. Med. Chem. 36, 1090-99 (1993).
  3. D.H. Boschelli, D.T. Conner, D.A. Bornemeir, R.D. Dyer, J.A. Kennedy, P.J. Kuipers, G.C. Okonkwo, D.J. Schrier and C.D. Wright, J. Med. Chem. 36, 1802-10 (1993).
  4. D.H. Jones, R. Slack, S. Squires and K.H. Wooldridge, J. Med. Chem. 8, 676-80 (1965).
  5. R.W. Sidwell, R.K. Robins and I.W. Hillyard, Pharmacol. Ther. 6, 123-8 (1978).
  6. J.K. Sughenand T. Yologe, Pharm. Acta Helv. 58, 64-8 (1978).
  7. V.I. Kelarev, R.A. Karakhanov, S.Sh. Gasanvo, G.V. Morozova and K.P. Kuatbekova, J. Org. Chem. USSR, 323-9 (1993).
  8. Sh.A. Shams El-Dine and A.A.B. Hazza, Pharmazie 29, 761-8 (1974).
  9. T. Misato, K. Ko, Y. Honma and E. Taniyama, Jpn Kokai 77 25 028 (1977) [Chem. Abstr. 87, (1977) a]. J.H. Reisdorff, W. Brandes, H. Scheinpflug, B. Homeyer and P. Roessler, Ger. Offen. 2 533 604 (1977) [Chem. Abstr. 88, (1978) 137064b]. G. VanReet, J. Heeres and L. Wals, US Patent 4 160 838 (1979) [Chem. Abstr. 91, (1979) 175361z]. N.S. Habib, S. Abdel-Hamid and M. El-Hawash, Farmaco 44, 1225-32 (1989).
  10. M.R. Stillings, A.P. Welbour and D.S. Walter, J. Med. Chem. 29, 2280-84 (1986).
  11. J.M. Kane, M.A. Staeger, C.R. Dalton, F.P. Miller, M.W. Dubley, A.M.L. Ogden, J.H. Kehne, H.J. Ketteler, T.C. McCloskey, Y. Senyah, P.A. Chmielewski and J.A. Miller, J. Med. Chem. 37, 125-32 (1994).
  12. C. Ainsworth, N.R. Easton, M. Livezey, D.E. Morrison and W.R. Gibson, J. Am. Pharm. Assoc. 5, 383-9 (1962).
  13. C.B. Chapleo, M. Myers, P.L. Myers, J.F. Saville, A.C.B. Smith, M.R. Stillings, I.F. Tulloch, D.S. Walter and A.P. Welbour, J. Med. Chem. 29, 2273-80 (1986).
  14. J.M. Kane, M.W. Dubley, S.M. Sorenson and F.P. Miller, J. Med. Chem. 31, 1253-58 (1988).
  15. R.D. Porsolt, A. Bertinand M. Jalfre, Pharmacodyn. 229, 327-36 (1977).
  16. A. Vamvakides, Ann. Pharm. Fr. 48, 154-59 (1990).
  17. F. Fujikawa, I. Yamashita, T. Seno, M. Sasaki, M. Naito and S. Tsukuma, Yakugaku Zasshi 86 (a) (1966) 864 [Chem. Abstr. 65, (1966) 20086h]. L. Canoira, J. Gonzalo Rodriguez, J.B. Subirats, J.A. Escario, I. Jimenez and A.R. Martinez-Fernandez, Eur. J. Med. Chem. 24, 39-42 (1989).
  18. S. Masanori, O. Toshiharu, T. Hiroko and Y. Yoshitoku, Jpn. Kokai, Tokyo Koho JP 01 31 762 [89 31 762] (1989) [Chem. Abstr. 111, (1989) 153624s]. C. Krishna and K.C. Joshi, P. Chand. Pharmazie 37, 1-12 (1982).
  19. G.T. Seaborg, Science 9, 223 (1984).
  20. S.N. Sawhney, A. Gupta and P.K. Sharma, Indian J.